Laser Therapy

Low Level Laser Therapy (LLLT) Riancorp

Low Level Laser therapy (LLLT) is the treatment of various conditions using laser to bring about a photochemical reaction at a cellular level. The laser light penetrates into tissue where it is absorbed by cells and converted into energy that influences the course of metabolic processes.

The LTU-904 is an infrared laser operating at a wavelength of 904 nanometers. This invisible wavelength penetrates deeply into tissue (much deeper than the often used red laser operating in the visible red region).

 

Cleared by the FDA for Lymphedema Treatment:
The American Food and Drug Administration has cleared the Riancorp LTU-904 laser therapy units as a tool to be used in the treatment of postmastectomy lymphedema.

The LTU-904 is the ONLY laser device cleared by FDA for lymphedema treatment.

Specific advantages of the LTU-904 laser therapy include:

  • Simple and often immediate analgesic effect at the time of treatment

  • Dramatically shortened recovery time with rapid reduction of swelling and inflammation

  • Non-invasive and quick treatment

  • The LTU models are Class 1 lasers and therefore eye-safe for patients and clinicians

  • Responsive injuries

Laser therapy is recognized and used worldwide for the treatment of numerous injuries in humans and animals. The 904 nanometer wavelength of the LTU-904 is especially effective in the treatment of:

  • Lymphedema/lymphoedema

  • Slow healing skin wounds

  • Fibrous lesions

  • Sprained and strained ligaments

  • Tendon injuries

  • Muscle soreness

The LTU can be used in conjunction with ultrasonic therapy, physiotherapy, chiropractic therapy and concurrent with most other therapy.

Full details of the treatment methods for various injuries are provided in the comprehensive owner's manual which is included with the unit.